Taysha Gene Therapies, Inc. — All Filings
377 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-115202 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-115177 | Mar 19, 2026 | — |
| 144 | — | 0002086827-26-000008 | Feb 27, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001081 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001493215-26-000050 | Feb 17, 2026 | — |
| 4 | — | 0001793412-26-000012 | Feb 6, 2026 | Feb 4, 2026 |
| SCHEDULE 13G/A | — | 0000315066-26-000536 | Feb 5, 2026 | — |
| 144 | — | 0001977343-26-000005 | Feb 4, 2026 | — |
| 144 | — | 0001979666-26-000006 | Feb 4, 2026 | — |
| 144 | — | 0001979693-26-000007 | Feb 4, 2026 | — |
| 144 | — | 0002086827-26-000006 | Feb 4, 2026 | — |
| 144 | — | 0001793412-26-000010 | Feb 4, 2026 | — |
| 4 | — | 0001665124-26-000008 | Jan 27, 2026 | Jan 23, 2026 |
| 4 | — | 0001569926-26-000008 | Jan 27, 2026 | Jan 23, 2026 |
| 4 | — | 0001793412-26-000008 | Jan 27, 2026 | Jan 23, 2026 |
| 144 | — | 0001569926-26-000006 | Jan 23, 2026 | — |
| 144 | — | 0001665124-26-000006 | Jan 23, 2026 | — |
| 144 | — | 0002086827-26-000004 | Jan 23, 2026 | — |
| 144 | — | 0001979666-26-000004 | Jan 23, 2026 | — |
| 144 | — | 0001977343-26-000003 | Jan 23, 2026 | — |
| 144 | — | 0001979693-26-000005 | Jan 23, 2026 | — |
| 144 | — | 0001793412-26-000006 | Jan 23, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000794 | Jan 21, 2026 | — |
| 4 | — | 0001793412-26-000002 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | — | 0001569926-26-000002 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | — | 0001665124-26-000002 | Jan 14, 2026 | Jan 12, 2026 |
| 144 | — | 0001974158-26-000011 | Jan 12, 2026 | — |
| S-8 | S-8 | 0001193125-26-004622 | Jan 6, 2026 | — |
| 4 | — | 0001665124-25-000003 | Dec 1, 2025 | Nov 28, 2025 |
| 144 | — | 0001974158-25-000077 | Nov 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016718 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001231919-25-000491 | Nov 14, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-263634 | Nov 4, 2025 | — |
| 8-K | 8-K | 0001193125-25-263543 | Nov 4, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-263506 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-241415 | Oct 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-235212 | Oct 9, 2025 | — |
| 8-K | 8-K | 0001193125-25-227505 | Oct 2, 2025 | — |
| 144 | — | 0002086827-25-000002 | Sep 22, 2025 | — |
| 4 | — | 0001415889-25-024369 | Sep 12, 2025 | Sep 10, 2025 |
| 144 | — | 0001974158-25-000058 | Sep 10, 2025 | — |
| 4 | — | 0001415889-25-022750 | Aug 22, 2025 | Aug 21, 2025 |
| 4 | — | 0001415889-25-022749 | Aug 22, 2025 | Aug 21, 2025 |
| 144 | — | 0001415889-25-022689 | Aug 21, 2025 | — |
| 144 | — | 0001415889-25-022687 | Aug 21, 2025 | — |
| 144 | — | 0001415889-25-022685 | Aug 21, 2025 | — |
| 144 | — | 0001415889-25-022683 | Aug 21, 2025 | — |
| 144 | — | 0001415889-25-022681 | Aug 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-022033 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021712 | Aug 14, 2025 | — |